As the nation awaits to join the chorus singing hosannas to a new president—whoever that may be—to be announced in the course of the day, he will be instantly coronated with the thorny crown of the ...
After disclosing data from the phase II Herald study, Aligos Therapeutics Inc. may sign a partner to help advance ALG-055009, a thyroid hormone receptor (THR) beta agonist, in subjects with metabolic ...